Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rafael Carmena

Showing results (1-10 of 79) with videos related to

Pageof 8
Sort By:
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|May 19, 2022
Rafael Carmena
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|June 7, 2021
Arteriosclerosis and other diseases in heads of government and its consequences for the populationRafael Carmena
American Heart Journal|November 18, 2005
Type 2 diabetes, dyslipidemia, and vascular risk: rationale and evidence for correcting the lipid imbalanceRafael Carmena
Blood Pressure|March 6, 2024
Present and future of drug therapy in hypertension: an overviewJosep Redon, Rafael Carmena
Medicina Clinica|March 16, 2005
[Relevance of metabolic syndrome and its definition depending on the criteria employed]José T Real, Rafael Carmena
Current Atherosclerosis Reports|May 1, 2019
Diabetogenic Action of Statins: MechanismsRafael Carmena, D John Betteridge
Medicina Clinica|November 9, 2007
[New targets in patients with cardiometabolic risk]Luis Miguel Ruilope, Rafael Carmena
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|September 14, 2015
[Importance of dyslipidaemia in cardiovascular disease: a point of view]Juan F Ascaso, Rafael Carmena
Seminars in Vascular Medicine|April 30, 2005
Statins and diabetesRafael Carmena, D John Betteridge
Medicina Clinica|January 5, 2010
[Global therapy of diabetic dyslipidemia: benefits and new therapeutic approaches]Rafael Carmena, Juan F Ascaso
Pageof 8

Showing results (1-10 of 79) with videos related to

Sort By:
Pageof 8
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|May 19, 2022
Rafael Carmena
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|June 7, 2021
Arteriosclerosis and other diseases in heads of government and its consequences for the populationRafael Carmena
American Heart Journal|November 18, 2005
Type 2 diabetes, dyslipidemia, and vascular risk: rationale and evidence for correcting the lipid imbalanceRafael Carmena
Blood Pressure|March 6, 2024
Present and future of drug therapy in hypertension: an overviewJosep Redon, Rafael Carmena
Medicina Clinica|March 16, 2005
[Relevance of metabolic syndrome and its definition depending on the criteria employed]José T Real, Rafael Carmena
Current Atherosclerosis Reports|May 1, 2019
Diabetogenic Action of Statins: MechanismsRafael Carmena, D John Betteridge
Medicina Clinica|November 9, 2007
[New targets in patients with cardiometabolic risk]Luis Miguel Ruilope, Rafael Carmena
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|September 14, 2015
[Importance of dyslipidaemia in cardiovascular disease: a point of view]Juan F Ascaso, Rafael Carmena
Seminars in Vascular Medicine|April 30, 2005
Statins and diabetesRafael Carmena, D John Betteridge
Medicina Clinica|January 5, 2010
[Global therapy of diabetic dyslipidemia: benefits and new therapeutic approaches]Rafael Carmena, Juan F Ascaso
Pageof 8